Učitavanje...
Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition
LRH-1 is a nuclear receptor that regulates lipid metabolism and homeostasis, making it an attractive target for the treatment of diabetes and non-alcoholic fatty liver disease. Building on recent structural information about ligand binding from our labs, we have designed a series of new LRH-1 agonis...
Spremljeno u:
| Izdano u: | Bioorg Med Chem Lett |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7701997/ https://ncbi.nlm.nih.gov/pubmed/32631515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2020.127293 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|